Filing Flows › Comparisons › SHC vs VMD
Sotera Health vs Viemed Healthcare: SHC and VMD compared
Sotera Health is the larger company: $325M of revenue in its latest quarter (Q3 2026) against $80.7M for Viemed Healthcare (Q3 2026). Viemed Healthcare is growing faster (+12% against +4% a year earlier). Sotera Health is more profitable, with an operating margin of 25.8% against 8.6%.
Where the money goes: SHC and VMD
Sotera Health (SHC) · Q3 2026
Sotera Health, Q3 2026: revenue $325M (+4% year over year), operating margin 25.8%, net earnings $58.4M, operating cash flow $111M. The chart follows the revenue to costs, profit and cash.
Viemed Healthcare (VMD) · Q3 2026
Viemed Healthcare, Q3 2026: revenue $80.7M (+12% year over year), operating margin 8.6%, net earnings $4.6M, operating cash flow $11.5M. The chart follows the revenue to costs, profit and cash.
| Sotera Health (SHC) | Viemed Healthcare (VMD) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $325M | $80.7M |
| Revenue growth, Y/Y | +4% | +12% |
| Gross margin | 55.6% | 57.3% |
| Operating margin | 25.8% | 8.6% |
| Net earnings | $58.4M | $4.6M |
| Net margin | 18.0% | 5.7% |
| Operating cash flow | $111M | $11.5M |
| Free cash flow | $57.7M | $4.0M |
| Market value | $5.2B | — |
| P/E | 30.2× | — |
| Analysts’ mean target | $21.94 | — |
Where the revenue comes from
Sotera Health
- Sterigenics: $209M (64%)
- Nelson Labs: $60.6M (19%)
- Nordion: $55.0M (17%)
Questions
Which is bigger, Sotera Health or Viemed Healthcare?
Sotera Health is the larger company: $325M of revenue in its latest quarter (Q3 2026) against $80.7M for Viemed Healthcare (Q3 2026).
Is Sotera Health or Viemed Healthcare growing faster?
Viemed Healthcare is growing faster (+12% against +4% a year earlier).
Which is more profitable, Sotera Health or Viemed Healthcare?
Sotera Health is more profitable, with an operating margin of 25.8% against 8.6%.
More: Sotera Health earnings · how Sotera Health makes money · Viemed Healthcare earnings · how Viemed Healthcare makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.